Colorectal Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for colorectal cancer.

Showing 15 trials
Titlesort icon Investigator
A Phase I Study of IMMU-130 in Patients with Colorectal Cancer
[Protocol 11-074]
Segal, Neil, MD, PhD
A Phase I Study of MEDI3617 in Patients with Advanced Solid Tumors
[Protocol 11-052]
Rizvi, Naiyer, MD
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117]
Gounder, Mrinal, MD
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137]
Kemeny, Nancy, MD
A Phase III Study of Celecoxib in Young People with Familial Adenomatous Polyposis
[Protocol 10-176]
Guillem, Jose, MD
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
[Protocol 11-194]
Ginex, Pamela, RN, EDD
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
[Protocol 05-001]
Chi, Dennis, MD
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients
[Protocol 04-144]
Stadler, Zsofia, MD
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051]
Offit, Kenneth, MD
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068]
Stadler, Zsofia, MD
Examination of Tissue from Ablated Malignant Liver Metastases to Predict Outcome
[Protocol 09-122]
Sofocleous, Constantinos, MD, PhD
Hereditary Colorectal Cancer Family Registry
[Protocol 01-110]
Guillem, Jose, MD
Measurement of Rectal Cancer Oxygenation
[Protocol 10-121]
Guillem, Jose, MD
Pilot Evaluation of Radioimmunodetection of 124Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients with Colorectal Cancer
[Protocol 03-124]
Larson, Steven, MD
The Sexual Health of Rectal Cancer Patients: A Pilot Study
[Protocol 08-073]
DuHamel, Katherine, PhD